States' Drug Pricing Boards Could Brew New Legal Tests
Amgen Inc.'s ongoing challenge to a Colorado law regulating retail drug prices could serve as a litmus test for widespread state government efforts to keep medication costs low....To view the full article, register now.
Already a subscriber? Click here to view full article